chr3-165023746-A-G

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001041.4(SI):​c.2923T>C​(p.Tyr975His) variant causes a missense change. The variant allele was found at a frequency of 0.00496 in 1,610,422 control chromosomes in the GnomAD database, including 28 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0048 ( 8 hom., cov: 32)
Exomes 𝑓: 0.0050 ( 20 hom. )

Consequence

SI
NM_001041.4 missense

Scores

3
8
6

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:3

Conservation

PhyloP100: 3.70

Publications

15 publications found
Variant links:
Genes affected
SI (HGNC:10856): (sucrase-isomaltase) This gene encodes a sucrase-isomaltase enzyme that is expressed in the intestinal brush border. The encoded protein is synthesized as a precursor protein that is cleaved by pancreatic proteases into two enzymatic subunits sucrase and isomaltase. These two subunits heterodimerize to form the sucrose-isomaltase complex. This complex is essential for the digestion of dietary carbohydrates including starch, sucrose and isomaltose. Mutations in this gene are the cause of congenital sucrase-isomaltase deficiency.[provided by RefSeq, Apr 2010]
SI Gene-Disease associations (from GenCC):
  • congenital sucrase-isomaltase deficiency
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, PanelApp Australia, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.025785983).
BP6
Variant 3-165023746-A-G is Benign according to our data. Variant chr3-165023746-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 344034.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00482 (730/151534) while in subpopulation AMR AF = 0.0118 (178/15120). AF 95% confidence interval is 0.0104. There are 8 homozygotes in GnomAd4. There are 329 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 8 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001041.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SI
NM_001041.4
MANE Select
c.2923T>Cp.Tyr975His
missense
Exon 26 of 48NP_001032.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SI
ENST00000264382.8
TSL:1 MANE Select
c.2923T>Cp.Tyr975His
missense
Exon 26 of 48ENSP00000264382.3

Frequencies

GnomAD3 genomes
AF:
0.00481
AC:
729
AN:
151416
Hom.:
8
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00135
Gnomad AMI
AF:
0.00987
Gnomad AMR
AF:
0.0118
Gnomad ASJ
AF:
0.00579
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.00132
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.00625
Gnomad OTH
AF:
0.00817
GnomAD2 exomes
AF:
0.00420
AC:
1049
AN:
249710
AF XY:
0.00434
show subpopulations
Gnomad AFR exome
AF:
0.00111
Gnomad AMR exome
AF:
0.00582
Gnomad ASJ exome
AF:
0.00558
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000786
Gnomad NFE exome
AF:
0.00584
Gnomad OTH exome
AF:
0.00937
GnomAD4 exome
AF:
0.00497
AC:
7253
AN:
1458888
Hom.:
20
Cov.:
31
AF XY:
0.00505
AC XY:
3666
AN XY:
725754
show subpopulations
African (AFR)
AF:
0.00132
AC:
44
AN:
33314
American (AMR)
AF:
0.00618
AC:
275
AN:
44514
Ashkenazi Jewish (ASJ)
AF:
0.00550
AC:
143
AN:
26010
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39512
South Asian (SAS)
AF:
0.00179
AC:
154
AN:
86218
European-Finnish (FIN)
AF:
0.00109
AC:
58
AN:
53378
Middle Eastern (MID)
AF:
0.0153
AC:
88
AN:
5752
European-Non Finnish (NFE)
AF:
0.00555
AC:
6163
AN:
1109994
Other (OTH)
AF:
0.00545
AC:
328
AN:
60196
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
344
688
1033
1377
1721
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
222
444
666
888
1110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00482
AC:
730
AN:
151534
Hom.:
8
Cov.:
32
AF XY:
0.00444
AC XY:
329
AN XY:
74056
show subpopulations
African (AFR)
AF:
0.00135
AC:
56
AN:
41456
American (AMR)
AF:
0.0118
AC:
178
AN:
15120
Ashkenazi Jewish (ASJ)
AF:
0.00579
AC:
20
AN:
3452
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5132
South Asian (SAS)
AF:
0.00124
AC:
6
AN:
4822
European-Finnish (FIN)
AF:
0.00132
AC:
14
AN:
10622
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.00627
AC:
424
AN:
67620
Other (OTH)
AF:
0.00808
AC:
17
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
38
76
113
151
189
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00549
Hom.:
16
Bravo
AF:
0.00570
TwinsUK
AF:
0.00566
AC:
21
ALSPAC
AF:
0.00441
AC:
17
ESP6500AA
AF:
0.000908
AC:
4
ESP6500EA
AF:
0.00558
AC:
48
ExAC
AF:
0.00400
AC:
485
Asia WGS
AF:
0.00115
AC:
4
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:2
Jul 16, 2024
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Reported as a single heterozygous variant or with a second SI variant, phase unknown, in patients with functional gastrointestinal disorders and abnormal sucrase activity from duodenal biopsy (PMID: 32732636); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 34426522, 37790351, 36878682, 32732636, 29408290, 31331993, 37349966)

Sep 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SI: BP4, BS1

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Sucrase-isomaltase deficiency Uncertain:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.

Feb 28, 2020
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SI-related disorder Benign:1
Sep 29, 2023
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.24
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.19
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.54
D
Eigen
Uncertain
0.66
Eigen_PC
Uncertain
0.58
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Benign
0.68
T
MetaRNN
Benign
0.026
T
MetaSVM
Uncertain
-0.076
T
MutationAssessor
Pathogenic
3.7
H
PhyloP100
3.7
PrimateAI
Benign
0.46
T
PROVEAN
Pathogenic
-4.5
D
REVEL
Uncertain
0.51
Sift
Uncertain
0.014
D
Sift4G
Uncertain
0.015
D
Polyphen
1.0
D
Vest4
0.64
MVP
0.95
MPC
0.24
ClinPred
0.051
T
GERP RS
5.2
Varity_R
0.42
gMVP
0.75
Mutation Taster
=74/26
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146785675; hg19: chr3-164741534; API